Violich Capital Management’s Merck MRK Stock Holding History

Violich Capital Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.46M	Hold	50,257	–	–	0.7%	31
2026 Q1	$6.05M	Buy	50,257 +50	+0.1%	+$5.77K	0.71%	29
2025 Q4	$5.28M	Sell	50,207 -19,685	-28%	-$1.85M	0.59%	32
2025 Q3	$5.87M	Sell	69,892 -6,400	-8%	-$527K	0.7%	31
2025 Q2	$6.04M	Sell	76,292 -7,900	-9%	-$628K	0.85%	27
2025 Q1	$7.56M	Sell	84,192 -2,100	-2%	-$196K	1.02%	25
2024 Q4	$8.58M	Sell	86,292 -4,937	-5%	-$509K	1.12%	22
2024 Q3	$10.4M	Buy	91,229 +800	+0.9%	+$95K	1.35%	20
2024 Q2	$11.2M	Buy	90,429 +2,752	+3%	+$354K	1.51%	16
2024 Q1	$11.6M	Buy	87,677 +2,760	+3%	+$340K	1.66%	17
2023 Q4	$9.26M	Buy	84,917 +800	+1%	+$83K	1.5%	19
2023 Q3	$8.66M	Sell	84,117 -2,900	-3%	-$313K	1.48%	20
2023 Q2	$10M	Sell	87,017 -900	-1%	-$102K	1.62%	19
2023 Q1	$9.35M	Hold	87,917	–	–	1.59%	19
2022 Q4	$9.75M	Hold	87,917	–	–	1.73%	20
2022 Q3	$7.57M	Sell	87,917 -153	-0.2%	-$13.7K	1.43%	21
2022 Q2	$8.03M	Sell	88,070 -6	-0%	-$532	1.41%	21
2022 Q1	$7.23M	Sell	88,076 -235	-0.3%	-$18.5K	1.07%	26
2021 Q4	$6.77M	Buy	88,311 +1,600	+2%	+$127K	0.97%	29
2021 Q3	$6.51M	Buy	86,711 +3,100	+4%	+$236K	1.05%	26
2021 Q2	$6.5M	Sell	83,611 -4,013	-5%	-$298K	1.09%	25
2021 Q1	$6.45M	Buy	87,624 +12,665	+17%	+$934K	1.16%	24
2020 Q4	$5.85M	Buy	74,959 +105	+0.1%	+$8.03K	1.13%	25
2020 Q3	$5.92M	Buy	74,854 +10,165	+16%	+$796K	1.25%	24
2020 Q2	$4.77M	Buy	64,689 +16,978	+36%	+$1.28M	1.04%	27
2020 Q1	$3.5M	Hold	47,711	–	–	0.94%	29
2019 Q4	$4.14M	Buy	47,711 +1,310	+3%	+$108K	0.9%	28
2019 Q3	$3.73M	Sell	46,401 -498	-1%	-$39.9K	0.9%	30
2019 Q2	$3.75M	Sell	46,899 -1,624	-3%	-$124K	0.92%	31
2019 Q1	$3.85M	Hold	48,523	–	–	0.98%	28
2018 Q4	$3.54M	Sell	48,523 -524	-1%	-$37K	1%	28
2018 Q3	$3.32M	Sell	49,047 -53	-0.1%	-$3.38K	0.76%	36
2018 Q2	$2.84M	Sell	49,100 -2,043	-4%	-$115K	0.72%	35
2018 Q1	$2.66M	Sell	51,143 -3,019	-6%	-$163K	0.71%	37
2017 Q4	$2.91M	Sell	54,162 -1,074	-2%	-$59.5K	0.74%	37
2017 Q3	$3.38M	Sell	55,236 -629	-1%	-$38.1K	0.92%	34
2017 Q2	$3.42M	Sell	55,865 -94	-0.2%	-$5.72K	1%	33
2017 Q1	$3.39M	Hold	55,959	–	–	1.03%	32
2016 Q4	$3.44M	Sell	55,959 -472	-0.8%	-$27.6K	1.06%	32
2016 Q3	$3.36M	Buy	56,431 +289	+0.5%	+$16.9K	1.18%	31
2016 Q2	$3.09M	Sell	56,142 -80	-0.1%	-$4.26K	0.97%	30
2016 Q1	$2.84M	Sell	56,222 -5,083	-8%	-$249K	0.91%	30
2015 Q4	$3.09M	Buy	61,305 +1,127	+2%	+$56.8K	1.02%	31
2015 Q3	$2.84M	Buy	60,178 +1,162	+2%	+$61.7K	0.99%	29
2015 Q2	$3.21M	Sell	59,016 -1,624	-3%	-$91.1K	1.05%	28
2015 Q1	$3.33M	Sell	60,640 -5,974	-9%	-$338K	1.08%	29
2014 Q4	$3.61M	Sell	66,614 -21,776	-25%	-$1.21M	1.15%	28
2014 Q3	$5M	Sell	88,390 -1,123	-1%	-$63.1K	1.63%	21
2014 Q2	$4.94M	Sell	89,513 -2,913	-3%	-$159K	1.65%	22
2014 Q1	$5.01M	Buy	92,426 +367	+0.4%	+$19K	1.74%	19
2013 Q4	$4.4M	Sell	92,059 -4,797	-5%	-$219K	1.58%	24
2013 Q3	$4.4M	Buy	96,856 +314	+0.3%	+$14.3K	1.72%	20
2013 Q2	$4.28M	Buy	+96,542	New	+$4.31M	1.73%	18

Other funds holding MRK

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Violich Capital Management's MRK Position: Q2 2026 in Review

Violich Capital Management held its Merck (MRK) position steady in Q2 2026 at 50,257 shares worth $6.46M. The position accounts for 0.7% of the portfolio, ranked #31.

Violich Capital Management first reported a position in MRK in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.6M in Q1 2024. 1,660 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Violich Capital Management held 50,257 shares of Merck worth $6.46M as of Q2 2026.
Violich Capital Management left its Merck share count unchanged in Q2 2026.
Merck made up 0.7% of Violich Capital Management's portfolio in Q2 2026, its #31 holding.
Violich Capital Management first reported a position in Merck in Q2 2013 and has held it in 53 quarters since.
Violich Capital Management's Merck position peaked at $11.6M in Q1 2024.
1,660 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Violich Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.